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Adverse effects of polychlorinated biphenyls 
(PCBs) on neurodevelopment have been well 
documented by growing evidence from in vivo 
and in vitro studies (Bemis and Seegal 2004; 
Carpenter et al. 2002; Ozcan et al. 2004; 
Seegal et al. 2005; Tan et al. 2004) and from 
epidemiologic studies (Darvill et al. 2000; 
Gladen et al. 1988; Jacobson and Jacobson 
1996; Patandin et al. 1999; Rogan and Gladen 
1991; Walkowiak et al. 2001). Although the 
mechanisms for this effect are still not well 
understood, one hypothesis is disruption of 
thyroid hormone homeostasis (Porterfield and 
Hendry 1998).
Over the past decade, there has been 
increasing research on hydroxylated PCBs 
(OH-PCBs), which are formed by cytochrome 
P450–mediated oxidation from PCBs (Letcher 
et al. 2000). Unlike PCBs, which are relatively 
stable and highly lipophilic, OH-PCBs are 
readily excreted. Nevertheless, several studies 
have observed detectable levels of OH-PCBs 
in both animals and humans (Bergman 
et al. 1994; Hovander et al. 2002; Park et al. 
2007; Soechitram et al. 2004). Soechitram 
et al. (2004) found that OH-PCB levels in 
umbilical cord plasma were approximately 
50% of maternal concentrations, whereas the 
parent PCBs concentrations in cord plasma 
were around 30% of maternal levels. The 
authors suggested that this difference may be 
explained by active transport of OH-PCBs 
across the placenta and hydroxylation of PCBs 
by the fetus itself, whereas transplacental 
transfer is the only source of fetal PCBs. In 
our study population (Park et al. 2007), the 
median cord-to-maternal ratios were 0.75 for 
the sum of OH-PCBs and 0.18 for the sum of 
PCBs from wet-weight–based concentrations. 
This result supports both transport across the 
placenta of these metabolites and the potential 
for greater impact on the fetus, compared with 
the parent PCB compounds.
Although in vitro and in vivo studies have 
shown adverse effects of OH-PCBs on thy-
roid or sex hormone homeostasis (Meerts 
et al. 2002, 2004a; Vakharia and Gierthy 
2000), their health effects have scarcely been 
studied in humans. Researchers in Japan 
found OH-PCBs predicted higher free thy-
roxine (fT4) in neonates (Otake et al. 2007). 
Meerts et al. (2002) observed reduced levels 
of total thyroxine (T4) in fetal plasma and 
brain samples in rats after prenatal exposure to 
4-OH-CB-107, one of the predominant PCB 
metabolites detected in humans. Also, the 
same research group reported developmental 
neurotoxicity of 4-OH-CB-107 in exposed 
Wistar rats, including impaired habituation 
and alterations in latencies to movement 
onset, indicative of deficits in learning and 
memory (Meerts et al. 2004b). Thus, com-
peting binding affinity of OH-PCBs versus 
T4 might be a potential pathway to trans-
port these hazardous chemicals to the brain, 
which may lead to subsequent impacts on 
  neurodevelopment.
Even though the production of PCBs was 
prohibited in other countries beginning in 
the late 1970s, PCBs were manufactured by 
Chemko Inc., in Michalovce, a district in east-
ern Slovakia, until 1985. Discharges of PCBs 
into the environment resulted in widespread 
contamination of the local river and lake, pro-
viding pathways of human exposures in these 
areas. We launched a birth cohort study in 
eastern Slovakia in 2002, and followed up the 
children at 16 months of age to investigate the 
possible adverse effects of PCBs and metabo-
lites on neurocognitive function.
In this study we evaluated associations 
between prenatal OH-PCB exposure and 
neurodevelopment in 16-month-old children 
in eastern Slovakia.
Materials and Methods
Study population. During 2002–2004, we 
recruited pregnant women at the time of 
delivery from two areas in eastern Slovakia: 
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Ba c k g r o u n d: Hydroxylated polychlorinated biphenyls (OH-PCBs), unlike PCBs, are in general 
readily excreted yet are still detected in humans and animals. Active transport of OH-PCBs across 
the placenta and hydroxylation of PCBs by the fetus suggest the potential for greater impact on the 
fetus compared with the parent PCB compounds, but little is known about their health effects, par-
ticularly in humans.
oBjectives: The objective of this study was to evaluate the associations between prenatal OH-PCB 
exposure and neurodevelopment in children at 16 months of age in eastern Slovakia.
Me t h o d s : A birth cohort (n = 1,134) was enrolled during 2002–2004. We analyzed six OH-PCB 
metabolites (4-OH-CB-107, 3-OH-CB-153, 4-OH-CB-146, 3´-OH-CB-138, 4-OH-CB-187, and 
4´-OH-CB-172) in a subset of the cohort. The Bayley Scales of Infant Development were admin-
istered to the children at the 16-month follow-up visit. We developed multiple linear regression 
models predicting standardized scores for the Mental Development Index (MDI) and Psychomotor 
Development Index (PDI) from maternal (n = 147) and cord (n = 80) serum OH-PCB concen-
trations, adjusting for sex of child, district, HOME (Home Observation for Measurement of the 
Environment) score, and maternal score on Raven’s Progressive Matrices.
re s u l t s: Cord 4-OH-CB-107 was significantly associated with lower MDI (β = –2.27; p = 0.01) 
and PDI (β = –4.50; p = 0.004). Also, maternal 4-OH-CB-107 was significantly associated with 
lower MDI (β = –1.76; p = 0.03) but not PDI. No other OH-PCB metabolites were associated with 
decreased PDI or MDI.
co n c l u s i o n s: Our findings showed a significant association of 4-OH-CB-107 with decreased 
MDI, which can possibly be mediated by endocrine disruption, altered neurotransmitter functions, 
or reduced thyroid hormone concentrations in brain.
key w o r d s : Bayley Scales of Infant Development, hydroxylated PCBs, Slovakia. Environ Health 
Perspect 117:1600–1606 (2009).  doi:10.1289/ehp.0900611 available via http://dx.doi.org/ [Online 
20 May 2009]Hydroxylated PCBs and child neurodevelopment
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 10 | October 2009  1601
Michalovce, with high levels of PCBs from a 
chemical manufacturing plant, and Svidnik, 
located around 70 km to the northwest, with 
substantially lower average levels of PCBs. 
There is only one hospital in each district, 
where most deliveries occur. For eligibility 
criteria, we excluded mothers who had more 
than four previous births, were < 18 years of 
age at the time of delivery, lived < 5 years in 
their district, or had a major illness during 
pregnancy. We also excluded infants with 
severe birth defects. Further details on recruit-
ment and data collection can be found else-
where (Hertz-Picciotto et al. 2003).
Of 1,134 eligible participants, PCB mea-
surements in maternal serum and in cord 
serum were available, at the time of this data 
analysis, for 1,076 and 469, respectively. 
Because of budget constraints, we measured 
OH-PCBs in maternal (n = 202) and cord 
sera (n = 92) for subsets within the cohort; we 
sampled randomly within strata defined by 
maternal PCB levels, with intensive sampling 
of the highest PCB levels (> 75th percentile) 
to increase statistical power. The resulting 
samples for maternal sera consisted of 42% 
below the 75th percentile, 20% in the 75th–
85th percentile, 24% in the 85–95th percen-
tile, and 14% above the 95th percentile. After 
sampling, 55 and 12 infants, respectively, did 
not complete the Bayley Scales, leaving 147 
from maternal serum (122 from Michalovce 
and 25 from Svidnik) and 80 from cord 
serum (63 from Michalovce and 17 from 
Svidnik) for analysis of neurodevelopment.
Institutional review boards of University 
of California–Davis and the Slovak Medical 
University approved this study. Informed 
consent to all study subjects was given before 
participation. All data and specimens were col-
lected only after written consent was obtained.
Specimen collection. A trained nurse col-
lected maternal blood specimens at delivery 
(~ 20 mL) using venipuncture into vacutainer 
tubes (S-Monovette Serum tubes; Sarstedt, 
Nümbrecht, Germany). To collect cord blood, 
the infant was held at the level of the introitus 
or the mother’s abdomen to prevent a sig-
nificant shift of the infant’s blood volume. As 
soon as possible after suctioning, the cord was 
clamped and cut 4–5 cm from the infant’s 
abdomen. After the infant was dried and sta-
bilized and the umbilical base appeared nor-
mal, an umbilical clamp was secured to the 
cord 1–2 cm distal to the abdominal wall, and 
any excess length was cut. Cord blood collec-
tion (30–35 mL) was done by the obstetri-
cian or assisting nurse. All tubes of maternal 
and cord blood specimens were refrigerated at 
5–10°C immediately after collection. Samples 
were transported to the biochemistry depart-
ment of each local hospital within 2 hr for the 
next procedure. Serum was isolated by cen-
trifugation (15 min at 3,000 rpm) and stored 
frozen at –18°C. These were transported to 
the Slovak Medical University in Bratislava, in 
thermo boxes with cooling cartridges to pre-
vent thawing, and stored at –18°C. Aliquots 
of 5 mL were shipped to the University of 
California–Davis and stored at –80°C until 
analysis of OH-PCB metabolites.
OH-PCB  measurement.  We  have 
described the analytical method in a previ-
ous report (Park et al. 2007). In summary, we 
adapted a series of techniques for extraction of 
OH-PCBs from the serum and separation of 
substance groups: denaturation (hydrochloric 
acid and 2-propanol), liquid/liquid extraction 
(methyl tert-butyl ether:hexane 1:1), potas-
sium chloride wash, and potassium hydrox-
ide phase separation. The OH-PCBs in the 
sample extracts and calibration standards were 
methylated by adding diazomethane that was 
synthesized as described elsewhere (Sandau 
2000). We treated the extracts with concen-
trated sulfuric acid (98%) followed by further 
cleanup on a sulfuric acid:silica gel column 
(1:2; 0.5 g) using dichloromethane:hexane 
(1:1; 10 mL) as the mobile phase. We analyzed 
the final extract by using gas chromatography 
(Agilent 6890N; Agilent Technologies, Palo 
Alto, CA, USA)/mass spectrometry (Agilent 
5973N; Agilent Technologies) equipped with 
DB-5MS capillary column (30 m × 0.25 mm 
inner diameter, 0.25 µm film thickness; J&W 
Scientific, Folsom, CA, USA). 4´-OH-CB-
159 (2.00 ng) and CB-209 (3.15 ng) were 
spiked as a recovery internal standard and 
an injection standard, respectively. We cor-
rected serum concentrations of OH-PCBs by 
using the recoveries of the internal standard 
and subtraction of the quantity measured in 
each reagent blank analyzed with every batch. 
The method was initially set up in close col-
laboration with scientists at the Department 
of Environmental Chemistry at Stockholm 
University who started this research field. We 
then carried out interlaboratory comparisons 
with the Centers for Disease Control and 
Prevention (Atlanta, GA, USA) by analyzing 
their quality control samples: bovine serum 
spiked with OH-PCB congeners.
Neurodevelopment assessment. One local 
psychologist in each district at the 16-month 
follow-up visit administered the Bayley Scales 
of Infant Development II (Bayley 1993), an 
individual assessment for evaluating devel-
opment of children at 1–42 months of age, 
consisting of two scales: The mental scale 
measures cognitive development and con-
sists of items to evaluate the child’s memory, 
habituation, and problem solving, whereas 
the psychomotor scale evaluates control of 
the gross and fine motor skills. We calculated 
Psychomotor Development Index (PDI) and 
Mental Development Index (MDI) scores 
based on the raw scores, which we then 
standardized with adjustment for the child’s 
actual age. We used the standardized scores 
as the outcomes of interest. All instruments 
used in this study were translated into the 
Slovak language. We videotaped 34 children 
in each district, and the psychologist in the 
other district reviewed and scored the tapes 
for an evaluation of reliability.
Data collection. The data for covariates 
were obtained from an interview with the 
mother conducted by trained staff during the 
5-day hospital stay and from the newborn 
medical record. The interview data included 
information on sociodemographic character-
istics, past pregnancies, medical conditions, 
and medication history before and during the 
pregnancy. After delivery, each mother was 
assessed on the Raven’s Progressive Matrices 
(Raven 2002), a test of nonverbal intelligence. 
The respondent is asked to identify the miss-
ing segment that completes a visual geometric 
pattern; this task requires abstract reasoning. 
To assess the quality and quantity of stimula-
tion given to children in the home environ-
ment, each psychologist also administered the 
Home Observation for Measurement of the 
Environment (HOME) instrument (Bradley 
and Caldwell 1984) at the clinics during the 
16-month follow-up visit. HOME provides 
a systematic evaluation of the nurturing envi-
ronment of the child based on an interview 
with the parent and an observation of the 
home by the interviewer. Because we admin-
istered HOME at the clinics rather than at 
the homes, we deleted three questions from 
the original version regarding direct observa-
tions of play materials in the home. Based on 
a birth cohort study from Dusseldorf, scores 
from this modified version were highly corre-
lated with scores from the full scale (Winneke 
G, Walkowiak J, personal communication).
Data analysis. Maternal and cord 
OH-PCB concentrations, the primary pre-
dictor variables of interest, were skewed 
(Shapiro–Wilk test, p < 0.0001), and hence 
were natural-log transformed. They were not 
lipid adjusted because of high water solubil-
ity of these metabolites; values are therefore 
expressed as nanograms per gram of serum 
(i.e., on a wet-weight basis).
We fitted linear regression models with 
the MDI or the PDI as outcomes in four 
separate sets of models: two for each out-
come in relation to exposures from each of 
the two different media, maternal and cord 
sera. The six most abundant OH-PCB con-
geners—4-OH-CB-107, 3-OH-CB-153, 
4-OH-CB-146, 3´-OH-CB-138, 4-OH-
CB-187, and 4´-OH-CB-172—were each 
analyzed in relation to Bayley scores using 
multiple linear regression models that 
included covariates from a previously devel-
oped model of the Bayley Scales in which 
prenatal PCBs were the exposures of inter-
est (Park et al. 2009); in that previous data Park et al.
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analysis, MDI or PDI scores were regressed 
on each potential covariate in a separate 
model to determine the strength of the bivari-
ate associations. Then we fit multiple linear 
regression models with all covariates showing 
a bivariate association with the PDI or MDI 
where p < 0.3 and implemented a backward 
elimination approach with a criterion of a 
change in estimate of ≥ 10% (Mickey and 
Greenland 1989) for inclusion of potential 
confounders. Covariates thereby selected for 
the final regression models were sex, HOME 
score, mother’s Raven score, and district.
In all models, we adjusted for the sam-
pling design of stratified sampling without 
replacement based on strata of maternal PCB 
concentrations. We performed these analyses 
in the SUDAAN statistical package (version 
9.0.2; Research Triangle Institute, Research 
Triangle Park, NC, USA).
Results
Table 1 describes characteristics of the two 
sample subsets used in this analysis as well as 
the full cohort with maternal PCB measure-
ments (n = 1,076). Overall, most of the basic 
characteristics were similar among the two sub-
set groups and the original cohort. However, 
there were slight differences in some factors 
compared with the original cohort: More 
mothers with high school education, more 
female children, and fewer Romani subjects (an 
ethnic minority in Europe) were in the subset 
of the cohort used for the present analysis.
The arithmetic means for the sum of 
OH-PCB metabolites before natural log-
transformation from maternal and cord 
sera were 0.671 and 0.497 ng/g wet weight, 
respectively (Table 2). Overall, OH-PCB 
concentrations from the cord sera were lower 
than those from maternal sera. 4-OH-CB-187 
and 4-OH-CB-146 were, respectively, the 
most and second most abundant congeners in 
both maternal and cord sera.
Results of models for scores on the MDI, 
after adjustment for residential district, HOME 
score, sex, and Raven’s score of mother, showed 
no significant associations with the sum of 
the OH-PCB congeners either from mater-
nal or from cord serum (Table 3). In adjusted 
models predicting the MDI from individual 
OH-PCB congeners, we observed no associa-
tions, except with 4-OH-CB-107, which was 
significant for maternal and for cord serum. In 
both cases, higher levels of this metabolite were 
associated with lower scores on the MDI (cord: 
β = – 2.27, SE = 0.87, p = 0.01; maternal: 
β = –1.76, SE = 0.80, p = 0.03).
Similar to results for MDI, the adjusted 
models of the PDI also indicated no asso-
ciation with the sum of OH-PCB congeners, 
regardless of whether these measurements 
were in maternal or in cord serum. The PDI 
was also not associated with any of the six 
individual OH-PCBs in maternal serum. 
However, in cord serum, 4-OH-CB-107 was 
again significantly associated with a lower 
PDI score (β = –4.50, SE = 1.52, p = 0.004). 
Although not statistically significant, coeffi-
cients for all cord OH-PCBs in relation to the 
PDI were negative; that is, higher levels were 
associated with poorer scores. However, this 
was not observed for maternal OH-PCBs.
Table 4 shows the full multiple regression 
models of the Bayley Scales (MDI and PDI) 
as a function of 4-OH-CB-107 (natural log 
transformed, nanograms per gram wet weight) 
in maternal and cord sera. The interpretation 
of these models is that, adjusting for con-
founding, an increase from the 25th to the 
75th percentile of cord 4-OH-CB-107 con-
centration (0.008–0.033 ng/g wet weight) pre-
dicts a 6.4-point and 3.2-point reduction in 
PDI and MDI, respectively. For comparison, 
one SD for these scores in our study is equal 
Table 1. Characteristics of the study groups in the cohort from two districts of eastern Slovakia, 2002–2004.
Mother (n = 147) Cord (n = 80) Cohort (n = 1,076)
Characteristic No. (%)a No. (%)a No. (%)
District
  Michalovce 122 (71.6) 63 (68.7) 757 (70.4)
  Svidnik 25 (28.4) 17 (31.3) 319 (29.6)
Maternal age (years)
  18–19  8 (5.1)  4 (3.5) 93 (8.6)
  20–29 103 (75.5) 61 (81.0) 760 (70.6)
  ≥ 30 36 (19.5) 15 (15.5) 223 (20.8)
Maternal education
  Basic schooling 28 (16.8) 16 (16.3) 229 (21.3)
  High school without graduation 40 (22.5) 17 (18.2) 277 (25.7)
  High school with graduation 73 (58.8) 44 (62.2) 487 (45.2)
  More than college/university 6 (2.9) 3 (3.3) 78 (7.3)
  Missing 0 (0) 0 (0) 5 (0.5)
Sex of child
  Male 67 (41.1) 37 (40.1) 555 (51.6)
  Female 80 (58.9) 43 (59.9) 521 (48.4)
Ethnicity
  Slovakian/other 121 (84.8) 68 (86.7) 821 (76.3)
  Romani 22 (14.1) 11 (12.8) 228 (21.2)
  Missing 4 (1.1) 1 (0.5) 27 (2.5)
Marital status
  Married or living with partner 132 (91.6) 76 (94.9) 978 (90.9)
  Never married 9 (5.6) 2 (2.7) 63 (5.9)
  Divorced/widowed 4 (2.3) 1 (1.9) 31 (2.8)
  Missing 2 (0.5) 1 (0.5) 4 (0.4)
Maternal smoking
  No 83 (61.3) 49 (65.9) 662 (61.5)
  Yes 60 (37.6) 30 (33.6) 385 (35.8)
  Missing 4 (1.1)  1 (0.5) 29 (2.7)
Maternal alcohol consumption
  No 96 (62.9) 47 (57.2) 720 (66.9)
  Yes 47 (36.0) 32 (42.3) 328 (30.5)
  Missing 4 (1.1)  1 (0.5) 28 (2.6)
Parity
 0 66 (47.3) 37 (47.8) 446 (41.4)
 1 36 (24.8) 22 (29.0) 352 (32.7)
 2 30 (17.7) 15 (15.7) 186 (17.3)
 3 13 (9.5) 6 (7.5) 87 (8.1)
 4 1 (0.3) 0 (0) 2 (0.2)
  Missing 1 (0.3) 0 (0) 3 (0.3)
Maternal hyper- or hypothyroidism history
  No 141 (96.4) 77 (95.7) 1,016 (94.4)
  Yes 2 (2.5) 2 (3.8) 33 (3.1)
  Missing 4 (1.1) 1 (0.5) 27 (2.5)
Maternal diabetes history
  No 143 (98.9) 79 (99.5) 1,036 (96.3)
  Yes 0 (0) 0 (0) 13 (1.2)
  Missing 4 (1.1) 1 (0.5) 27 (2.5)
MDI
  Mean 93.6 92.8
  SD 13.5 13.4
PDI
  Mean 99.8   100.3
  SD 15.6 14.9
aWeighted percentage due to the sampling design.Hydroxylated PCBs and child neurodevelopment
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 10 | October 2009  1603
to 14 points for MDI and 15 points for PDI. 
In maternal serum, the interquartile increment 
(0.014–0.041 ng/g wet weight) in 4-OH-CB-
107 is associated with a 1.8-point decrement 
in MDI. Thus, the magnitude of association 
was larger for the cord measurements com-
pared with the maternal measurements.
With regard to other covariates, female 
children had higher MDI and PDI scores com-
pared with male children. For example, in the 
model from the maternal 4-OH-CB-107, girls 
scored approximately 7 and 4 points higher 
than did boys in MDI and PDI, respectively. 
Overall, higher HOME and maternal Raven’s 
scores were associated with higher MDI and 
PDI. District of residence was a strong predic-
tor of PDI: Children from Svidnik showed 
approximately a 9-point decrement compared 
with children from Michalovce.
We fitted separate regression models for 
MDI and PDI with maternal serum data from 
Michalovce only (n = 122), the district with 
the more experienced psychologist. We still 
found a significant association of the maternal 
4-OH-CB-107 with MDI, but not with PDI 
(MDI: β = –1.95, SE = 1.89, p = 0.02; PDI: 
β = –0.99, SE = 0.83, p = 0.60).
Discussion
To our knowledge, this is the first study to 
investigate neurodevelopment in humans in 
relation to OH-PCBs. We found no asso-
ciation between the sum of the measured 
OH-PCBs in either maternal or cord serum 
and neurodevelopmental scores. However, 
cord levels of the individual metabolite 4-OH-
CB-107 were significantly associated with 
reduced PDI and MDI, whereas maternal 
concentrations of this same congener showed a 
significant association with decreased MDI but 
not PDI. Thus, deficits in MDI were consis-
tently associated with greater prenatal exposure 
to the specific metabolite 4-OH-PCB-107, 
regardless of whether maternal or cord serum 
was used for measurement of this compound. 
This is interesting because 4-OH-PCB-107 
is a metabolite of both PCB-105 and PCB-
118, toxicologically acting as dioxin-like and 
non-dioxin-like PCB congeners, but generally 
categorized as dioxin-like PCBs. Also, these 
PCB congeners are present in the original 
PCB product, Delor, produced at Michalovce 
in rather high concentrations.
In vivo and in vitro studies on animals and 
their tissues as well as one human study have 
shown adverse effects of OH-PCBs on thy-
roid hormones. Otake et al.  (2007) observed 
higher neonatal fT4 in association with total 
OH-PCBs and with 4-OH-CB-187, the most 
abundant hydroxylated metabolite in most 
human studies (Park et al 2007). Rodent stud-
ies observed reduced total T4 levels in fetal 
plasma and brain samples in rats after pre-
natal exposure to 4-OH-CB-107 (Meerts 
et al. 2002) or the PCB mixture Aroclor 1254 
(Morse et al. 1996).
These observed reductions of thyroid 
hormones were possibly related to the strong 
binding affinity of OH-PCBs to transthyretin 
(TTR), resulting from structural similar-
ity (Chauhan et al. 2000) of OH-PCBs to 
T4. Considering the fact that TTR can 
pass the placental and blood–brain barri-
ers (McKinnon et al. 2005; Schreiber et al. 
Table 3. Estimated coefficients [β (95% confidence intervals)] of OH-PCB concentrations in multiple linear 
regression models predicting Bayley Scales of Infant Development in 16-month-old children from eastern 
Slovakia, 2002–2004.a 
Log-transformed exposure variables MDI PDI
Maternal sera (n = 147)
  4-OH-CB-107 –1.76 (–3.34 to –0.17)* –1.66 (–5.40 to 2.10)
  3-OH-CB-153 0.56 (–1.54 to 2.66) 1.71 (–0.89 to 4.30)
  4-OH-CB-146 –0.18 (–1.77 to 1.40) 1.29 (–1.55 to 4.14)
  3´-OH-CB-138 0.23 (–1.81 to 2.27) 1.73 (–0.95 to 4.41)
  4-OH-CB-187 –0.11 (–2.12 to 1.89) 0.90 (–1.90 to 3.70)
  4´-OH-CB-172 0.46 (–1.50 to 2.42) 0.88 (–1.55 to 3.32)
  Sum of six OH-PCBs –0.13 (–2.15 to 1.90) 0.96 (–2.00 to 3.92)
Cord sera (n = 80)
  4-OH-CB-107 –2.27 (–4.00 to –0.54)* –4.50 (–7.52 to –1.48)**
  3-OH-CB-153 0.31 (–2.55 to 3.17) –2.21 (–6.34 to 1.92)
  4-OH-CB-146 –0.13 (–2.83 to 2.56) –1.52 (–5.74 to 2.69)
  3´-OH-CB-138 0.20 (–2.60 to 3.00) –1.97 (–6.09 to 2.15)
  4-OH-CB-187 0.17 (–2.52 to 3.07) –1.61 (–5.99 to 2.76)
  4´-OH-CB-172 0.52 (–2.07 to 3.11) –1.21 (–4.82 to 2.40)
  Sum of six OH-PCBs –0.11 (–2.94 to 2.71) –2.29 (–6.75 to 2.16)
Regression parameter coefficients represent one score change in PDI and MDI for a one-unit change in loge exposure 
concentration (ng/g wet weight).
aAfter adjusting for district, HOME, sex, Raven score from multiple linear regression models. *p < 0.05; **p < 0.01.
Table 4. Multiple linear regression models for effects of 4-OH-CB-107 in maternal and cord sera on the 
Bayley Scales (MDI and PDI) in 16-month-old children born in eastern Slovakia, 2002–2004 [β (95% confi-
dence intervals)].
Variable MDI PDI
Maternal sera (n = 147)
  4-OH-CB-107 –1.76 (–3.34 to –0.17)* –1.66 (–5.40 to 2.10)
  District: Michalovce versus Svidnik 1.19 (–2.78 to 5.16) –8.87 (–14.5 to –3.26)**
  HOME score 0.87 (0.56 to 1.19)**  0.52 (0.03 to 1.07)*
  Raven score 0.27 (0.14 to 0.40)**  0.52 (0.32 to 0.71)**
  Sex: female versus male 6.99 (3.77 to 10.2)** 4.24 (–0.41 to 8.90)
Cord sera (n = 80)
  4-OH-CB-107 –2.27 (–4.00 to –0.54)* –4.50 (–7.52 to –1.48)**
  District: Michalovce versus Svidnik 0.75 (–4.16 to 5.66) –9.20 (–15.43 to –2.96)**
  HOME score 0.78 (0.32 to 1.24)** –0.03 (–0.63 to 0.57)
  Raven score 0.32 (0.13 to 0.51)** 0.68 (0.41 to 0.95)**
  Sex: female versus male 4.96 (0.63 to 9.29)* 0.22 (–5.33 to 5.77)
Regression parameter coefficients represent one score change in PDI and MDI for a one-unit change in loge exposure 
concentration (ng/g wet weight).
*p < 0.05; **p < 0.01. 
Table 2. Distributions of OH-PCBs measured in maternal and cord sera (ng/g wet weight).
Congener
Percentile
Arithmetic mean ± SD 5th 25th 50th 75th 95th
Maternal sera (n = 147)
4-OH-CB-107 0.007 0.014 0.023 0.041 0.126 0.037 ± 0.046
3-OH-CB-153 0.017 0.041 0.063 0.099 0.265 0.086 ± 0.083
4-OH-CB-146 0.024 0.061 0.089 0.156 0.436 0.147 ± 0.222
3´-OH-CB-138 0.014 0.031 0.056 0.086 0.177 0.074 ± 0.071
4-OH-CB-187 0.053 0.106 0.175 0.309 0.801 0.273 ± 0.364
4´-OH-CB-172 0.010 0.023 0.032 0.063 0.139 0.054 ± 0.079
Sum of OH-PCBs 0.149 0.302 0.469 0.739 1.981 0.671 ± 0.805
Cord sera (n = 80)
4-OH-CB-107 0.004 0.008 0.012 0.033 0.086 0.028 ± 0.045
3-OH-CB-153 0.010 0.028 0.040 0.056 0.179 0.055 ± 0.054
4-OH-CB-146 0.024 0.040 0.073 0.109 0.380 0.114 ± 0.174
3´-OH-CB-138 0.015 0.032 0.058 0.085 0.217 0.074 ± 0.075
4-OH-CB-187 0.036 0.069 0.115 0.199 0.507 0.171 ± 0.211
4´-OH-CB-172 0.010 0.023 0.058 0.085 0.217 0.055 ± 0.056
Sum of OH-PCBs 0.112 0.220 0.340 0.539 1.495 0.497 ± 0.600Park et al.
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1995), OH-PCBs bound with TTR could 
potentially be transported to the brain, leading 
to subsequent impacts on neurodevelopment. 
TTR is a secondary thyroid hormone trans-
port protein after thyroxine-binding globulin 
(TBG) (Brouwer et al. 1998) in humans, in 
contrast with rodents, for which TTR is the 
primary carrier protein. It is unclear whether 
the observed negative effects by 4-OH-CB-
107 in our study were related to this competi-
tive binding affinity of OH-PCB metabolites 
to TTR. However, Cheek et al. (1999) found 
that 4-OH-CB-107 did not show a high 
binding affinity for other thyroid hormone 
transport proteins such as TBG in humans.
Alteration of steroid hormone homeosta-
sis by PCBs has been studied, and research-
ers suggested that estrogen-like activity 
might change brain dopamine concentra-
tion (Seegal et al. 1990, 1997) or aromatase 
activity (Woodhouse and Cooke 2004). It is 
known that exposure to gonadal steroids such 
as estrogens and androgens during early life 
might alter function or morphology of some 
areas of the brain such as the hippocampus, 
which is critical for learning and memory, 
especially in spatial domains (Schantz and 
Widholm 2001). Several studies demonstrat-
ing estrogenic and antiestrogenic activities of 
OH-PCBs (Connor et al. 1997; Kramer and 
Giesy 1999; Kramer et al. 1997; Matthews 
and Zacharewski 2000; Vakharia and Gierthy 
2000) provide evidence that exposure to 
OH-PCBs could affect neurodevelopment by 
mimicking or antagonizing these hormones.
The mechanism for neurotoxicity by 
4-OH-CB-107 is not known; however, anti-
estrogenicity (Moore et al. 1997) or estrogeni-
city (Machala et al. 2004) of 4-OH-CB-107 
might have the potential to affect neurode-
velopment adversely. A recent in vitro study 
showed that OH-PCBs were very potent 
inhibitors of the human estrogen sulfotrans-
ferase (hEST) (Kester et al. 2000), which 
catalyzes the sulfation and inactivation of 
estrogens. This inhibition of an estrogen inac-
tivator by OH-PCBs would make estradiol 
more available at the target tissue, resulting in 
estrogenic effects. Kester et al. (2000) reported 
4-OH-CB-107 to be the second strongest 
inhibitor of hEST [half-maximal inhibitory 
concentration (IC50), 0.15–0.25 nM] among 
32 OH-PCBs, and Purinton and Wood 
(2000) showed that ovine fetal estrogen sulfo-
transferase exists in brain regions such as the 
hypothalamus and brainstem. Based on these 
findings, it seems possible that 4-OH-CB-107 
affects neurodevelopment by enhancing estro-
gen through an indirect pathway, that is, inhi-
bition of estrogen sulfotransferase. Although 
4-OH-CB-187 and 4-OH-CB-146 were 
considered potent hEST inhibitors (Kester 
et al. 2000), we did not find similar associa-
tions with these measured major OH-PCBs. 
These associations might be absent because 
the compounds are far less potent—by more 
than an order of magnitude—inhibitors of 
hEST compared with 4-OH-CB  -107 (IC50, 
6.8–30.0 and 5.8–14.0 nM, respectively, vs. 
0.15–0.25 nM for 4-OH-CB  -107).
Meerts et al. (2004b) also reported devel-
opmental neurotoxicity from prenatal expo-
sure to 4-OH-CB-107 or Aroclor 1254, 
which they hypothesized to have been caused 
by disruption of dopaminergic and noradren-
ergic neurotransmission (Meerts et al. 2004b). 
Morse et al. (1996) found 4-OH-CB-107 
accumulated in fetal plasma and in forebrain 
of rats after maternal exposure to the PCB 
mixture Aroclor 1254.
4-OH-CB-107 is one of the major PCB 
metabolites in humans (Sandau et al. 2000; 
Sjödin et al. 2000), formed predominantly 
from PCB-105 and PCB-118 via a 1,2 shift 
mechanism (NIH shift) of chlorine (Letcher 
et al. 2000; Sandau et al. 2002). PCB-105 
and PCB-118 are known to be dioxin-like 
PCBs in chemical structure, and it is nota-
ble that Park et al. (2009) found dioxin-like 
PCBs (congeners 118 and 156) to be sig-
nificantly associated with decreased Bayley 
scores,  providing plausibility for the finding 
reported here. The non-dioxin-like PCBs did 
not predict 16-month Bayley MDI scores, 
nor did their metabolites. Some of the non-
dioxin-like PCBs (138 and 153) in cord 
serum were relatively significant in models of 
the PDI, and some of the largest coefficients 
for OH-PCBs, besides OH-CB-107, were 
the OH-metabolites of these two congeners 
in relation to PDI scores, even though sig-
nificance was not achieved. The consistently 
negative and large coefficients for serum 
OH-PCBs in relation to PDI is also strik-
ing. A study with greater power would be 
more definitive. Further evidence supporting 
metabolites as the active toxins is the more 
efficient transport of the OH-PCB metab-
olites across the placenta compared with 
the parent compounds (Park et al. 2007; 
Soechitram et al. 2004).
As to whether other chemicals can play a 
role as confounders, the levels of 2,3,7,8-sub-
stituted polychlorinated dibenzo-p-dioxins 
(PCDDs) and polychlorinated dibenzofurans 
(PCDFs) in serum samples in Michalovce and 
Svidnik were comparable with those found 
in other European countries, in contrast to 
the PCB levels (Kocan A, personal commu-
nication). Thus, we cannot exclude the pos-
sibility of confounding by other persistent 
organic pollutants (POPs) such as PCDDs, 
PCDFs, and polybrominated diphenyl ethers 
(PBDEs), but this would require that they be 
causally related to deficits on the Bayley scores 
and also correlated with PCB metabolites. 
However, it seems rather unlikely that these 
POPs are associated with only one metabolite 
of PCBs, 4-OH-CB-107, and not with other 
metabolites in the study. For PBDEs, in gen-
eral, their sources would be different, so these 
compounds would be unlikely to correlate 
well with OH-PCB metabolites.
Because we tested many OH-PCBs in 
relation to Bayley scores, some results could 
be due to chance. However, the consistency 
of findings with regard to the single OH-PCB 
and the similar specificity of findings for the 
parent compounds would argue that these are 
not sporadic findings. Exploration of multiple 
different congeners of OH-PCBs is justified 
as part of a careful evaluation of a rich data set 
in the context of hypothesis-driven research 
(Rothman 1990). Moreover, the specific find-
ings should be interpreted based on biological 
mechanisms, with statistical significance play-
ing one part in the weighing of evidence.
In this study, the means ± SD of the MDI 
for maternal and cord groups were 93 ± 14 
and 92 ± 15, respectively. In general, the stan-
dardized scores have means of 100 in the pop-
ulations for which they are standardized; for 
example, at 15 months of age, mean ± SD 
is 100 ± 15 (Bayley 1993). Different ethnic 
backgrounds have their own traditions that 
may influence learning and development, so 
children from other cultures may not perform 
appropriately on an assessment such as the 
Bayley Scales that have been normalized with 
American children. The Bayley test has not 
been standardized in the Slovak population; 
therefore, some cross-cultural or language dif-
ferences might have played a role in the lower 
MDI scores in our study (Gagnon and Nagle 
2000). After consultation with a member of 
our scientific advisory committee and an expe-
rienced psychologist, our team in Slovakia 
modified certain pictures of animals and home 
equipment to correspond to Slovakian culture 
and used them in the assessment of children. 
Notably, a recent Japanese study also observed 
lower mean MDI scores (92 ± 6) (Nakajima 
et al. 2006) similar to those for the Slovak 
population. Because our research objective was 
to investigate possible PCB metabolite asso-
ciations with Bayley scores within this study 
cohort, the standardization issue is less cru-
cial. Thus, although comparisons with other 
populations might not be valid, the absolute 
scores are not the focus of our investigation 
because the comparisons were internal within 
the Slovak population.
One psychologist in each district adminis-
tered the Bayley assessment in the study. For 
evaluation of reliability, 34 children in each 
district were videotaped, and the psychologist 
in the other district reviewed the tapes. We 
observed good agreement on the MDI (Pearson 
correlation coefficient = 0.85) between rat-
ers. However, the reliability on PDI could not 
be evaluated because the children frequently 
moved out of range of the video camera in Hydroxylated PCBs and child neurodevelopment
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order to complete the PDI tasks. Thus, we can-
not exclude the possibility of poor reliability 
on PDI among psychologists in each district, 
which might at least partially be a hindrance to 
valid estimation of the association with PDI.
In addition, the mean PDI scores in the 
two districts differed by a substantial margin 
of 9 points. It is possible that poor reliability 
across raters as discussed above, and/or some 
other unmeasured variables related to district, 
might have caused the substantial interdistrict 
difference in PDI. However, even when we 
fitted a model using the maternal serum data 
only from Michalovce, the district with the 
more experienced psychologist, we observed 
no significant association with PDI, whereas 
the association with MDI remained.
Because neurotoxic effects caused by haz-
ardous chemicals depend on various factors, 
such as the timing, concentration, and regions 
in the brain of exposure, it is possible that 
the same chemical exposure might not cause 
adverse effects on all domains of development 
(Mendola et al. 2002). Thus, prenatal 4-OH-
CB-107 exposure could specifically affect 
MDI but not PDI.
Park et al. (2007) compared levels of 
major OH-PCB metabolites in human speci-
mens from this Slovak study population with 
levels from four other countries: Netherlands, 
Canada, Sweden, and the Faroe Islands 
(Fängström et al. 2002; Guvenius et al. 2003; 
Sandau et al. 2000; Soechitram et al. 2004). 
The median concentration of major OH-PCB 
metabolites in maternal sera in the present 
study was 0.47 ng/g wet weight, comparable 
with levels observed from Faroe Island moth-
ers with low fish consumption and higher 
than Swedish and north Netherlands moth-
ers. Diets high in fish and sea mammals in 
Canada and in the Faroe Islands might be the 
source for high OH-PCBs (Park et al. 2007). 
Fish consumption is not, however, a major 
food source in the Slovak population, imply-
ing that this population in eastern Slovakia is 
exposed to PCBs from other sources; analysis 
of dietary patterns indicates that a leading 
contributor to PCB concentrations is pork 
(Sonneborn et al. 2008).
Although the original study (Park et al. 
2009) is one of a few large cohort studies in 
the world with high-quality measurements of 
low-level persistent pollutants, several limi-
tations not previously mentioned should be 
noted. First, the present study includes only 
a subset of the original cohort, which can lead 
to low statistical power because of the small 
sample size, especially for compounds with 
low variability. A second limitation was the 
refusal rate (47%) for participation in the 
original cohort. Selection bias can be an issue 
if exposed disease groups were more or less 
likely to be lost to follow-up than expected. 
However, we did not observe differences in 
levels of four major PCBs (congeners 138, 
153, 170, and 180) between participants and 
those who dropped out of the study. Although 
selection bias is always a possibility when 
response rates are low, it is difficult to envision 
how such bias would operate to create a strong 
artifactual association with a single congener 
and none with any of the others.
In conclusion, both maternal and cord 
4-OH-CB-107 were significantly associated 
with reduced MDI scores (p < 0.05), but the 
data were not as consistent for PDI. The cor-
respondence with our previous findings (Park 
et al. 2009) that prenatal PCB-118 and PCB-
156, two dioxin-like PCBs that are also par-
ent compounds for this metabolite, predict 
both lower MDI and PDI scores appears to 
support some specificity regarding the toxic 
compound. However, the explanation for the 
discrepancy between the parent PCB-118 and 
its metabolite 4-OH-CB-107 with regard to 
the PDI score is not clear. We did not find 
associations between other OH-PCB conge-
ners and the Bayley scores. In a smaller subset, 
we measured methylsulfonyl metabolites, but 
their levels were far lower than the OH-PCBs. 
The significant association of 4-OH-CB-107 
with decreased MDI is possibly mediated by 
endocrine disruption, altered neurotransmitter 
function, or reduced thyroid hormone in the 
central nervous system. Further epidemiologic 
studies with large sample size are necessary to 
confirm our findings.
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